10 20 30 40 50 60 70 80 1QLP - Header ----|----|----|----|----|----|----|----|----|----|----|----|----|----|----|----| Asymmetric UnitHEADER SERINE PROTEASE INHIBITOR 10-SEP-99 1QLP
TITLE 2.0 ANGSTROM STRUCTURE OF INTACT ALPHA-1-ANTITRYPSIN: A TITLE 2 CANONICAL TEMPLATE FOR ACTIVE SERPINS
COMPND MOL_ID: 1; COMPND 2 MOLECULE: ALPHA-1-ANTITRYPSIN; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: ALPHA-1-PROTEINASE INHIBITOR, COMPND 5 ALPHA-1-ANTIPROTEINASE; COMPND 6 ENGINEERED: YES
SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 ORGAN: LIVER; SOURCE 6 TISSUE: HEPATOCYTES; SOURCE 7 CELL: NEUTROPHILS; SOURCE 8 SECRETION: BLOOD; SOURCE 9 CELLULAR_LOCATION: CYTOPLASM; SOURCE 10 GENE: ALPHA-1-ANTITRYPSIN; SOURCE 11 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 12 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 13 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 14 EXPRESSION_SYSTEM_PLASMID: PTERMAT; SOURCE 15 EXPRESSION_SYSTEM_GENE: ALPHA-1-ANTITRYPSIN
KEYWDS SERINE PROTEASE INHIBITOR, SERPIN, GLYCOPROTEIN, SIGNAL, KEYWDS 2 POLYMORPHISM, EMPHYSEMA, DISEASE MUTATION, ACUTE PHASE
EXPDTA X-RAY DIFFRACTION
AUTHOR P.R.ELLIOTT,X.Y.PEI,T.DAFFORN,R.J.READ,R.W.CARRELL, AUTHOR 2 D.A.LOMAS
REVDAT 4 24-FEB-09 1QLP 1 VERSN REVDAT 3 11-MAR-02 1QLP 1 JRNL REVDAT 2 02-NOV-99 1QLP 1 ATOM REVDAT 1 27-SEP-99 1QLP 0
SPRSDE 27-SEP-99 1QLP 2PSI
JRNL AUTH P.R.ELLIOTT,X.Y.PEI,T.DAFFORN,D.A.LOMAS JRNL TITL TOPOGRAPHY OF A 2.0 A STRUCTURE OF JRNL TITL 2 ALPHA1-ANTITRYPSIN REVEALS TARGETS FOR RATIONAL JRNL TITL 3 DRUG DESIGN TO PREVENT CONFORMATIONAL DISEASE. JRNL REF PROTEIN SCI. V. 9 1274 2000 JRNL REFN ISSN 0961-8368 JRNL PMID 10933492
REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH P.R.ELLIOTT,J.-P.ABRAHAMS,D.A.LOMAS REMARK 1 TITL WILDTYPE ALPHA1-ANTITRYPSIN IS IN THE CANONICAL REMARK 1 TITL 2 INHIBITORY CONFORMATION REMARK 1 REF J.MOL.BIOL. V. 275 419 1998 REMARK 1 REFN ISSN 0022-2836 REMARK 1 PMID 9466920 REMARK 1 DOI 10.1006/JMBI.1997.1458
REMARK 2 REMARK 2 RESOLUTION. 2.0 ANGSTROMS.
REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 0.5 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES, PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.0 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 25.0 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.0 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 0.0 REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 93.6 REMARK 3 NUMBER OF REFLECTIONS : 25039 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : FREE R REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.231 REMARK 3 FREE R VALUE : 0.266 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.7 REMARK 3 FREE R VALUE TEST SET COUNT : 1271 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 10 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.0 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.07 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 72.9 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 1837 REMARK 3 BIN R VALUE (WORKING SET) : 0.297 REMARK 3 BIN FREE R VALUE : 0.334 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 4.7 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 96 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2956 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 0 REMARK 3 SOLVENT ATOMS : 106 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 29.41 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 38.38 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -4.094 REMARK 3 B22 (A**2) : 0.601 REMARK 3 B33 (A**2) : 3.493 REMARK 3 B12 (A**2) : 0.000 REMARK 3 B13 (A**2) : -6.005 REMARK 3 B23 (A**2) : 0.000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.28 REMARK 3 ESD FROM SIGMAA (A) : 0.24 REMARK 3 LOW RESOLUTION CUTOFF (A) : 0.0 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.34 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.25 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.006917 REMARK 3 BOND ANGLES (DEGREES) : 1.30665 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 24.95182 REMARK 3 IMPROPER ANGLES (DEGREES) : 1.23128 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 3.502 ; 1.5 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 4.732 ; 2.0 REMARK 3 SIDE-CHAIN BOND (A**2) : 2.219 ; 2.00 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 3.453 ; 2.5 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : CNS REMARK 3 KSOL : 1.257 REMARK 3 BSOL : 215 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : CNS_TOPPAR:PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : CNS_TOPPAR:WATER_REP.PARAM REMARK 3 PARAMETER FILE 3 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 TOPOLOGY FILE 2 : NULL REMARK 3 TOPOLOGY FILE 3 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: THE N-TERMINAL RESIDUES 1-22 WERE REMARK 3 NOT OBSERVED IN THE ELECTRON DENSITY MAPS
REMARK 4 REMARK 4 1QLP COMPLIES WITH FORMAT V. 3.15, 01-DEC-08
REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 13-SEP-99. REMARK 100 THE PDBE ID CODE IS EBI-4094.
REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 09-SEP-98 REMARK 200 TEMPERATURE (KELVIN) : 100.0 REMARK 200 PH : 6.00 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SRS REMARK 200 BEAMLINE : PX9.6 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.87 REMARK 200 MONOCHROMATOR : BENT CYLINDRICAL GE(111) REMARK 200 OPTICS : MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : CCP4 (SCALA) REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 25057 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.000 REMARK 200 RESOLUTION RANGE LOW (A) : 25.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 2.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 93.6 REMARK 200 DATA REDUNDANCY : 3.300 REMARK 200 R MERGE (I) : 0.07900 REMARK 200 R SYM (I) : 0.06700 REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 5.9000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.00 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.05 REMARK 200 COMPLETENESS FOR SHELL (%) : 95.2 REMARK 200 DATA REDUNDANCY IN SHELL : 2.40 REMARK 200 R MERGE FOR SHELL (I) : 0.51400 REMARK 200 R SYM FOR SHELL (I) : 0.41500 REMARK 200 <I/SIGMA(I)> FOR SHELL : 1.600 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: CNS 0.5 REMARK 200 STARTING MODEL: THERMOSTABLE VARIANT ALPHA1-ANTITRYPSIN (PDB REMARK 200 ENTRY 1PSI) REMARK 200 REMARK 200 REMARK: DATA WERE COLLECTED USING THE OSCILLATION METHOD.
REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 37.2 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.6 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 24% PEG 4000, 0.2 M SODIUM REMARK 280 ACETATE, 0.1M TRIS-HCL PH 6.0, 2MM FESO4.7H20
REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 57.34000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 19.63000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 57.34000 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 19.63000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL
REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA.
REMARK 350 REMARK 350 GENERATING THE BIOMOLECULE REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PQS REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000
REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 1 REMARK 465 ASP A 2 REMARK 465 PRO A 3 REMARK 465 GLN A 4 REMARK 465 GLY A 5 REMARK 465 ASP A 6 REMARK 465 ALA A 7 REMARK 465 ALA A 8 REMARK 465 GLN A 9 REMARK 465 LYS A 10 REMARK 465 THR A 11 REMARK 465 ASP A 12 REMARK 465 THR A 13 REMARK 465 SER A 14 REMARK 465 HIS A 15 REMARK 465 HIS A 16 REMARK 465 ASP A 17 REMARK 465 GLN A 18 REMARK 465 ASP A 19 REMARK 465 HIS A 20 REMARK 465 PRO A 21 REMARK 465 THR A 22
REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ALA A 70 -141.27 50.98 REMARK 500 PRO A 106 -91.16 -49.31 REMARK 500 ASP A 107 -14.45 -46.97 REMARK 500 GLN A 111 61.11 64.40 REMARK 500 HIS A 139 54.53 34.80 REMARK 500 ASN A 247 40.53 -106.72 REMARK 500 THR A 392 34.09 -78.89 REMARK 500 REMARK 500 REMARK: NULL
REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE):
REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 7API RELATED DB: PDB REMARK 900 MODIFIED ALPHA-1-ANTITRYPSIN (TETRAGONAL FORM 1) REMARK 900 RELATED ID: 8API RELATED DB: PDB REMARK 900 MODIFIED ALPHA-1-PROTEINASE INHIBITOR (HEXAGONAL) REMARK 900 RELATED ID: 9API RELATED DB: PDB REMARK 900 MODIFIED ALPHA-1-ANTITRYPSIN (TETRAGONAL FORM 2) REMARK 900 RELATED ID: 1PSI RELATED DB: PDB REMARK 900 INTACT RECOMBINED ALPHA-1-ANTITRYPSIN MUTANT PHE 51 TO LEU REMARK 900 RELATED ID: 2PSI RELATED DB: PDB REMARK 900 INTACT WILDTYPE RECOMBINANT ALPHA-1-ANTITRYPSIN REMARK 900 RELATED ID: 1ATU RELATED DB: PDB REMARK 900 UNCLEAVED ALPHA-1-ANTITRYPSIN REMARK 900 RELATED ID: 1KCT RELATED DB: PDB REMARK 900 ALPHA1-ANTITRYPSIN
DBREF 1QLP A 2 394 UNP P01009 A1AT_HUMAN 26 418
SEQADV 1QLP MET A 1 UNP P01009 CLONING ARTIFACT
SEQRES 1 A 394 MET ASP PRO GLN GLY ASP ALA ALA GLN LYS THR ASP THR SEQRES 2 A 394 SER HIS HIS ASP GLN ASP HIS PRO THR PHE ASN LYS ILE SEQRES 3 A 394 THR PRO ASN LEU ALA GLU PHE ALA PHE SER LEU TYR ARG SEQRES 4 A 394 GLN LEU ALA HIS GLN SER ASN SER THR ASN ILE PHE PHE SEQRES 5 A 394 SER PRO VAL SER ILE ALA THR ALA PHE ALA MET LEU SER SEQRES 6 A 394 LEU GLY THR LYS ALA ASP THR HIS ASP GLU ILE LEU GLU SEQRES 7 A 394 GLY LEU ASN PHE ASN LEU THR GLU ILE PRO GLU ALA GLN SEQRES 8 A 394 ILE HIS GLU GLY PHE GLN GLU LEU LEU ARG THR LEU ASN SEQRES 9 A 394 GLN PRO ASP SER GLN LEU GLN LEU THR THR GLY ASN GLY SEQRES 10 A 394 LEU PHE LEU SER GLU GLY LEU LYS LEU VAL ASP LYS PHE SEQRES 11 A 394 LEU GLU ASP VAL LYS LYS LEU TYR HIS SER GLU ALA PHE SEQRES 12 A 394 THR VAL ASN PHE GLY ASP THR GLU GLU ALA LYS LYS GLN SEQRES 13 A 394 ILE ASN ASP TYR VAL GLU LYS GLY THR GLN GLY LYS ILE SEQRES 14 A 394 VAL ASP LEU VAL LYS GLU LEU ASP ARG ASP THR VAL PHE SEQRES 15 A 394 ALA LEU VAL ASN TYR ILE PHE PHE LYS GLY LYS TRP GLU SEQRES 16 A 394 ARG PRO PHE GLU VAL LYS ASP THR GLU GLU GLU ASP PHE SEQRES 17 A 394 HIS VAL ASP GLN VAL THR THR VAL LYS VAL PRO MET MET SEQRES 18 A 394 LYS ARG LEU GLY MET PHE ASN ILE GLN HIS CYS LYS LYS SEQRES 19 A 394 LEU SER SER TRP VAL LEU LEU MET LYS TYR LEU GLY ASN SEQRES 20 A 394 ALA THR ALA ILE PHE PHE LEU PRO ASP GLU GLY LYS LEU SEQRES 21 A 394 GLN HIS LEU GLU ASN GLU LEU THR HIS ASP ILE ILE THR SEQRES 22 A 394 LYS PHE LEU GLU ASN GLU ASP ARG ARG SER ALA SER LEU SEQRES 23 A 394 HIS LEU PRO LYS LEU SER ILE THR GLY THR TYR ASP LEU SEQRES 24 A 394 LYS SER VAL LEU GLY GLN LEU GLY ILE THR LYS VAL PHE SEQRES 25 A 394 SER ASN GLY ALA ASP LEU SER GLY VAL THR GLU GLU ALA SEQRES 26 A 394 PRO LEU LYS LEU SER LYS ALA VAL HIS LYS ALA VAL LEU SEQRES 27 A 394 THR ILE ASP GLU LYS GLY THR GLU ALA ALA GLY ALA MET SEQRES 28 A 394 PHE LEU GLU ALA ILE PRO MET SER ILE PRO PRO GLU VAL SEQRES 29 A 394 LYS PHE ASN LYS PRO PHE VAL PHE LEU MET ILE GLU GLN SEQRES 30 A 394 ASN THR LYS SER PRO LEU PHE MET GLY LYS VAL VAL ASN SEQRES 31 A 394 PRO THR GLN LYS
FORMUL 2 HOH *106(H2 O1)
HELIX 1 1 ILE A 26 SER A 45 1 20 HELIX 2 2 SER A 53 LEU A 66 1 14 HELIX 3 3 LYS A 69 LEU A 80 1 12 HELIX 4 4 PRO A 88 ASN A 104 1 17 HELIX 5 5 VAL A 127 LEU A 137 1 11 HELIX 6 6 ASP A 149 THR A 165 1 17 HELIX 7 7 GLU A 199 THR A 203 5 5 HELIX 8 8 LYS A 259 LEU A 267 1 9 HELIX 9 9 THR A 268 ASN A 278 1 11 HELIX 10 10 LEU A 299 LEU A 303 1 5 HELIX 11 11 GLY A 304 GLY A 307 5 4 HELIX 12 12 THR A 309 SER A 313 5 5
SHEET 1 A 6 ILE A 50 PHE A 52 0 SHEET 2 A 6 PRO A 382 VAL A 388 -1 N LYS A 387 O ILE A 50 SHEET 3 A 6 PHE A 370 GLU A 376 -1 N MET A 374 O LEU A 383 SHEET 4 A 6 ALA A 248 PRO A 255 -1 N PHE A 253 O VAL A 371 SHEET 5 A 6 SER A 237 TYR A 244 -1 N TYR A 244 O ALA A 248 SHEET 6 A 6 ASN A 228 CYS A 232 -1 N CYS A 232 O SER A 237 SHEET 1 B 5 GLU A 141 VAL A 145 0 SHEET 2 B 5 LEU A 112 SER A 121 1 N LEU A 118 O GLU A 141 SHEET 3 B 5 PHE A 182 PHE A 190 -1 N PHE A 189 O THR A 113 SHEET 4 B 5 LYS A 331 ILE A 340 1 N LYS A 331 O LEU A 184 SHEET 5 B 5 LEU A 291 ASP A 298 -1 N TYR A 297 O HIS A 334 SHEET 1 C 4 GLU A 204 HIS A 209 0 SHEET 2 C 4 THR A 215 PHE A 227 -1 N MET A 220 O GLU A 204 SHEET 3 C 4 ARG A 282 PRO A 289 -1 N LEU A 288 O MET A 221 SHEET 4 C 4 PRO A 362 LYS A 365 1 N PRO A 362 O SER A 285
CRYST1 114.680 39.260 90.270 90.00 104.21 90.00 C 1 2 1 4
ORIGX1 1.000000 0.000000 0.000000 0.00000
ORIGX2 0.000000 1.000000 0.000000 0.00000
ORIGX3 0.000000 0.000000 1.000000 0.00000
SCALE1 0.008720 0.000000 0.002208 0.00000
SCALE2 0.000000 0.025471 0.000000 0.00000
SCALE3 0.000000 0.000000 0.011427 0.00000